Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls
Hiroki Masuda(Chiba University), Yohsuke Hirata(Iwate Medical University), Akiyuki Uzawa(Chiba University), Ryozo Kuwano(Tokyo Metropolitan University), Shinji Ochi(Sapporo Medical University Hospital), Yutaka Matsumura(University of Tsukuba), Yoshiyuki Hirano(Center for Forensic Mental Health, Chiba University), Ryohei Ohtani(Chiba University), Takeshi Kawarabayashi(Mayo Clinic), Junichiro Kanazawa(Sapporo Medical University Hospital), Rika Yamauchi(Sapporo Medical University Hospital), Masako Kudoh(Iwate Medical University), Hajime Sato(Tohoku University), Takeshi Ikeuchi(Niigata University Medical and Dental Hospital), Chiyoko Takanami(Sapporo Medical University Hospital), Hisashi Yonezawa(Iwate Medical University), Masahiro Mori(Kyoto University), Masato Hareyama(Kyoto University), Hiroyuki Arai(The University of Tokyo), Norihito Nakano, Seiju Kobayashi(Sapporo Medical University Hospital), Satoshi Takahashi(Sapporo Medical University), Michio Senda(Kyoto University), Hiroshi Matsuda(Kawamura Gakuen Women's University), Shigeki Hirano(Chiba University), Takashi Asada(Nagoya University), Takashi Nakata(Himeji Medical Center), Kenji Ishii(Tokyo Metropolitan Institute of Gerontology), Takeshi Iwatsubo(National Center of Neurology and Psychiatry), Eriko Tsukamoto, Masamitsu Hatakenaka(Sapporo Medical University Hospital), Naoko Nakahata(Hirosaki University Hospital), Takashi Hayashi(National Institute of Advanced Industrial Science and Technology), Shun Shimohama(Keio University), Yasuhito Wakasaya(Hirosaki University Hospital), Makoto Sasaki(Iwate Medical University), Tomohiko Uchida(Chiba University), Noriko Sato(National Center of Neurology and Psychiatry), Kengo Ito(National Center for Geriatrics and Gerontology), Junko Takahashi(Iwate Medical University), Shuichi Ono(Tohoku University), Takeshi Ando(Tokyo Metropolitan Ohtsuka Hospital), Yoshihiro Takai(Rohto Pharmaceutical (Japan)), Mayumi Muto(Chiba University), Masaki Saitoh(Sapporo Medical University Hospital), Etsuro Matsubara(Oita University), Morihiro Sugishita(Institute of Brain and Blood Vessels), Mikio Shoji(University Health Network)
Cited by 11
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k